09/05/2024 4:56 PM | Arcutis Biotherapeutics (Issuer) Welgus Howard G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 12:37 PM | Arcutis Biotherapeutics (Subject) Welgus Howard G. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024 3:39 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 4:43 PM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 3:45 PM | Arcutis Biotherapeutics (Subject) Welgus Howard G. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024 3:10 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
07/02/2024 6:13 PM | Arcutis Biotherapeutics (Issuer) Welgus Howard G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/26/2024 3:08 PM | Arcutis Biotherapeutics (Subject) Smither John W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024 3:47 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/18/2024 3:51 PM | Arcutis Biotherapeutics (Issuer) CHAUDHURI BHASKAR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:51 PM | Arcutis Biotherapeutics (Issuer) Gilbert Halley E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:51 PM | Arcutis Biotherapeutics (Issuer) LIN SUE-JEAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:51 PM | Arcutis Biotherapeutics (Issuer) Krishnamohan Neha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:52 PM | Arcutis Biotherapeutics (Issuer) Curran Terrie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:52 PM | Arcutis Biotherapeutics (Issuer) Heron Patrick J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:52 PM | Arcutis Biotherapeutics (Issuer) Welgus Howard G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:52 PM | Arcutis Biotherapeutics (Issuer) Leonard Keith R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:03 PM | Arcutis Biotherapeutics (Subject) Welgus Howard G. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 3:50 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 2:39 PM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 6:38 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 4:12 PM | Arcutis Biotherapeutics (Issuer) Edwards Larry Todd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 2:58 PM | Arcutis Biotherapeutics (Subject) Edwards Larry Todd (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024 3:08 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024 3:06 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 2:27 PM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 2:28 PM | Arcutis Biotherapeutics (Subject) Matsuda Masaru (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 2:29 PM | Arcutis Biotherapeutics (Subject) Moore Matthew Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 2:31 PM | Arcutis Biotherapeutics (Subject) Watanabe Todd Franklin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024 7:30 PM | Arcutis Biotherapeutics (Issuer) Topper David Joseph (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/11/2024 7:32 PM | Arcutis Biotherapeutics (Issuer) Topper David Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:12 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:14 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:08 PM | Arcutis Biotherapeutics (Issuer) Moore Matthew Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:09 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 11:40 AM | Arcutis Biotherapeutics (Subject) Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
03/06/2024 9:31 AM | Arcutis Biotherapeutics (Subject) JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G/A | |
03/04/2024 4:44 PM | Arcutis Biotherapeutics (Subject) OSBORNE DAVID W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 4:47 PM | Arcutis Biotherapeutics (Subject) Watanabe Todd Franklin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 4:38 PM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
03/04/2024 4:40 PM | Arcutis Biotherapeutics (Subject) Matsuda Masaru (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 4:42 PM | Arcutis Biotherapeutics (Subject) Moore Matthew Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:21 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
02/27/2024 3:34 PM | Arcutis Biotherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024 6:48 AM | Arcutis Biotherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/27/2024 6:44 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 5:36 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:47 PM | Arcutis Biotherapeutics (Issuer) Moore Matthew Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:23 PM | Arcutis Biotherapeutics (Issuer) Smither John W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:30 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:32 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:19 PM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I/A | |
02/15/2024 3:20 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 11:29 AM | Arcutis Biotherapeutics (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 8:26 AM | Arcutis Biotherapeutics (Subject) Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
02/12/2024 8:52 AM | Arcutis Biotherapeutics (Subject) MORGAN STANLEY (Filed by)
| Form SC 13G | |
02/12/2024 5:06 AM | Arcutis Biotherapeutics (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024 11:15 PM | Arcutis Biotherapeutics (Filer)
| Form EFFECT | |
02/08/2024 11:52 AM | Arcutis Biotherapeutics (Subject) JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G | |
01/31/2024 4:22 PM | Arcutis Biotherapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/29/2024 2:26 PM | Arcutis Biotherapeutics (Subject) BlackRock Inc. (Filed by)
| Form SC 13G | |
01/23/2024 9:26 AM | Arcutis Biotherapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024 3:28 PM | Arcutis Biotherapeutics (Issuer) Moore Matthew Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:30 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:32 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:34 PM | Arcutis Biotherapeutics (Issuer) Edwards Larry Todd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:35 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:03 AM | Arcutis Biotherapeutics (Subject)
| Form SC TO-I | |
01/03/2024 4:30 PM | Arcutis Biotherapeutics (Issuer) Burnett Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 1:29 PM | Arcutis Biotherapeutics (Subject) Burnett Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 4:24 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 2:26 PM | Arcutis Biotherapeutics (Subject) Turney Patricia A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 5:33 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 7:51 PM | Arcutis Biotherapeutics (Issuer) Watanabe Todd Franklin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2023 2:51 PM | Arcutis Biotherapeutics (Subject) Burrows Scott L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023 4:47 PM | Arcutis Biotherapeutics (Issuer) Matsuda Masaru (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 2:36 PM | Arcutis Biotherapeutics (Subject) Matsuda Masaru (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 12:13 PM | Arcutis Biotherapeutics (Subject) Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
11/13/2023 8:02 AM | Arcutis Biotherapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
11/09/2023 1:54 PM | Arcutis Biotherapeutics (Subject) PRUDENTIAL FINANCIAL INC (Filed by) PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
11/07/2023 2:33 PM | Arcutis Biotherapeutics (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
11/03/2023 6:32 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 6:36 AM | Arcutis Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023 3:23 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
10/23/2023 3:25 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 3:02 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 3:15 PM | Arcutis Biotherapeutics (Filer)
| Form 424B5 | |
10/03/2023 8:45 PM | Arcutis Biotherapeutics (Issuer) Edwards Larry Todd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 8:41 PM | Arcutis Biotherapeutics (Issuer) Edwards Larry Todd (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/27/2023 3:30 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
09/15/2023 3:07 PM | Arcutis Biotherapeutics (Filer)
| Form 10-K/A | |
09/15/2023 3:08 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
09/15/2023 3:09 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q/A | |
09/12/2023 6:39 AM | Arcutis Biotherapeutics (Issuer) Moore Matthew Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 5:48 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K/A | |